Lindsay J Caverly (Lindsay Caverly)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Topics

Pseudomonas Aeruginosa

Mass Spectrometry

Top Venues

Pediatric pulmonology

Annals of the American Thoracic Society

Antimicrobial agents and chemotherapy

Journal of the Pediatric Infectious Diseases Society

This page only lists publications with an associated author ORCID identifier.

Publications

Katherine S Dowdell, Sarah C Potgieter, Kirk Olsen, Soojung Lee, Matthew Vedrin, Lindsay J Caverly, John J LiPuma, Lutgarde Raskin
Source-to-tap investigation of the occurrence of nontuberculous mycobacteria in a full-scale chloraminated drinking water system. Applied and environmental microbiology (2024)
Stefanie Widder, Kristopher Opron, Lisa A Carmody, Linda M Kalikin, Lindsay J Caverly, John J LiPuma
Microbial community organization designates distinct pulmonary exacerbation types and predicts treatment outcome in cystic fibrosis. bioRxiv : the preprint server for biology (2023)
JooHee Choi, Eric C Keen, Meghan A Wallace, Skye Fishbein, Jerome Prusa, Madsen Zimbric, Carlos R Mejia-Chew, Shail B Mehta, Thomas C Bailey, Lindsay J Caverly, Carey-Ann D Burnham, Gautam Dantas
Genomic Analyses of Longitudinal Mycobacterium abscessus Isolates in a Multi-Center Cohort Reveal Parallel Signatures of In-Host Adaptation. The Journal of infectious diseases (2023)
Paul Breen, Madsen Zimbric, Kristopher Opron, Lindsay J Caverly
Sputum Metabolites Associated with Nontuberculous Mycobacterial Infection in Cystic Fibrosis. mSphere 7 (3) (2022)
Lindsay J Caverly
Can Identifying Pulmonary Exacerbation Phenotypes Guide New Treatment Approaches for Cystic Fibrosis? Annals of the American Thoracic Society 19 (11) (2022)
Lindsay J Caverly, Donald R VanDevanter
The Elusive Role of Airway Infection in Cystic Fibrosis Exacerbation. Journal of the Pediatric Infectious Diseases Society 11 (Supplement_2) (2022)
Madeleine A Ochs, Nicholas O Dillman, Lindsay J Caverly, Valerie D Nolt
Aminoglycoside dosing and monitoring for Pseudomonas aeruginosa during acute pulmonary exacerbations in cystic fibrosis. Pediatric pulmonology 56 (12) (2021)
Tara Gallagher, Stefan Riedel, Joseph Kapcia, Lindsay J Caverly, Lisa Carmody, Linda M Kalikin, Junnan Lu, Joann Phan, Matthew Gargus, Miki Kagawa, Simon W Leemans, Jason A Rothman, Felix Grun, John J LiPuma, Katrine L Whiteson
Liquid Chromatography Mass Spectrometry Detection of Antibiotic Agents in Sputum from Persons with Cystic Fibrosis. Antimicrobial agents and chemotherapy 65 (2) (2021)
Eric C Keen, JooHee Choi, Meghan A Wallace, Michelle Azar, Carlos R Mejia-Chew, Shail B Mehta, Thomas C Bailey, Lindsay J Caverly, Carey-Ann D Burnham, Gautam Dantas
Comparative Genomics of Mycobacterium avium Complex Reveals Signatures of Environment-Specific Adaptation and Community Acquisition. mSystems 6 (5) (2021)
Amy G Filbrun, Catherine Enochs, Lindsay J Caverly, Kelsey Rajala, Corey Powell, Emily Merrick, Samya Z Nasr
Quality improvement initiative to improve pulmonary function in pediatric cystic fibrosis patients. Pediatric pulmonology 55 (11) (2020)
Lindsay J Caverly, Junnan Lu, Lisa A Carmody, Linda M Kalikin, Kerby Shedden, Kristopher Opron, Michelle Azar, Shannon Cahalan, Bridget Foster, Donald R VanDevanter, Richard H Simon, John J LiPuma
Measures of Cystic Fibrosis Airway Microbiota during Periods of Clinical Stability. Annals of the American Thoracic Society 16 (12) (2020)
Stacey L Martiniano, Charles R Esther, Charles S Haworth, Shannon H Kasperbauer, Edith T Zemanick, Lindsay J Caverly
Challenging scenarios in nontuberculous mycobacterial infection in cystic fibrosis. Pediatric pulmonology 55 (2) (2019)
Lindsay J Caverly, Theodore Spilker, Linda M Kalikin, Terri Stillwell, Carol Young, David B Huang, John J LiPuma
In Vitro Activities of β-Lactam-β-Lactamase Inhibitor Antimicrobial Agents against Cystic Fibrosis Respiratory Pathogens. Antimicrobial agents and chemotherapy 64 (1) (2019)